Follow
Adam Penn-Nicholson
Adam Penn-Nicholson
Foundation for Innovative New Diagnostics (FIND)
Verified email at finddx.org - Homepage
Title
Cited by
Cited by
Year
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ...
The Lancet 387 (10035), 2312-2322, 2016
7442016
Biology of CCR5 and its role in HIV infection and treatment
MM Lederman, A Penn-Nicholson, M Cho, D Mosier
Jama 296 (7), 815-826, 2006
3552006
T-cell activation is an immune correlate of risk in BCG vaccinated infants
HA Fletcher, MA Snowden, B Landry, W Rida, I Satti, SA Harris, ...
Nature communications 7 (1), 11290, 2016
2892016
Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C
SC Ball, A Abraha, KR Collins, AJ Marozsan, H Baird, ...
Journal of virology 77 (2), 1021-1038, 2003
2592003
Four-gene pan-African blood signature predicts progression to tuberculosis
S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ...
American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018
2552018
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes
R Roy Chowdhury, F Vallania, Q Yang, CJ Lopez Angel, F Darboe, ...
Nature 560 (7720), 644-648, 2018
2392018
Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
DP Han, A Penn-Nicholson, MW Cho
Virology 350 (1), 15-25, 2006
2312006
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
TJ Scriba, A Penn-Nicholson, S Shankar, T Hraha, EG Thompson, ...
PLoS pathogens 13 (11), e1006687, 2017
2022017
Antigen availability shapes T cell differentiation and function during tuberculosis
AO Moguche, M Musvosvi, A Penn-Nicholson, CR Plumlee, H Mearns, ...
Cell host & microbe 21 (6), 695-706. e5, 2017
1702017
Safety and immunogenicity of the novel tuberculosis vaccine ID93+ GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase …
A Penn-Nicholson, M Tameris, E Smit, TA Day, M Musvosvi, ...
The Lancet Respiratory Medicine 6 (4), 287-298, 2018
1432018
A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis
D Wang, A Suhrbier, A Penn-Nicholson, J Woraratanadharm, J Gardner, ...
Vaccine 29 (15), 2803-2809, 2011
1402011
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting
A Penn-Nicholson, H Geldenhuys, W Burny, R van der Most, CL Day, ...
Vaccine 33 (32), 4025-4034, 2015
1232015
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
M Tameris, H Mearns, A Penn-Nicholson, Y Gregg, N Bilek, S Mabwe, ...
The lancet Respiratory medicine 7 (9), 757-770, 2019
1172019
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
TJ Scriba, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, SK Mbandi, ...
The Lancet Infectious Diseases 21 (3), 354-365, 2021
1052021
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi, E Thompson, SC Mendelsohn, S Suliman, ...
Scientific reports 10 (1), 8629, 2020
1042020
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study
A Penn-Nicholson, T Hraha, EG Thompson, D Sterling, SK Mbandi, ...
PLoS medicine 16 (4), e1002781, 2019
812019
Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry
BM Kagina, N Mansoor, EP Kpamegan, A Penn-Nicholson, E Nemes, ...
Journal of immunological methods 417, 22-33, 2015
692015
Detection of tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-infected persons on antiretroviral therapy
F Darboe, SK Mbandi, K Naidoo, N Yende-Zuma, L Lewis, EG Thompson, ...
Frontiers in microbiology 10, 451732, 2019
582019
Safety and immunogenicity of the adjunct therapeutic vaccine ID93+ GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo …
TA Day, A Penn-Nicholson, AKK Luabeya, A Fiore-Gartland, N Du Plessis, ...
The Lancet Respiratory Medicine 9 (4), 373-386, 2021
572021
Diagnostic accuracy of the Cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results
JS Sutherland, G van der Spuy, A Gindeh, NTT Thuong, AR Namuganga, ...
Clinical Infectious Diseases 74 (12), 2136-2141, 2022
562022
The system can't perform the operation now. Try again later.
Articles 1–20